Cogentix Medical (CGNT) stock price, revenue, and financials

Cogentix Medical market cap is $234.5 m, and annual revenue was $56.32 m in FY 2017

$234.5 M

CGNT Mkt cap, 31-May-2018

$56.3 M

Cogentix Medical Revenue FY, 2017
Cogentix Medical Revenue growth (FY, 2016 - FY, 2017), %9%
Cogentix Medical Gross profit (FY, 2017)37.4 M
Cogentix Medical Gross profit margin (FY, 2017), %66.5%
Cogentix Medical Net income (FY, 2017)-882.7 K
Cogentix Medical EBIT (FY, 2017)-889.5 K
Cogentix Medical Cash, 31-Dec-201720.9 M

Cogentix Medical Revenue

Cogentix Medical revenue was $56.32 m in FY, 2017 which is a 8.6% year over year increase from the previous period.

Embed Graph

Cogentix Medical Income Statement

Annual

USDFY, 2012FY, 2013FY, 2015FY, 2016FY, 2017

Revenue

16.7m15.3m26.5m51.9m56.3m

Revenue growth, %

95%9%

Cost of goods sold

11.6m10.9m3.1m16.2m18.9m

Gross profit

5.1m4.3m23.4m35.6m37.4m

Gross profit Margin, %

30%28%88%69%66%

Sales and marketing expense

20.2m21.3m22.9m

R&D expense

3.2m1.8m2.9m4.7m4.7m

General and administrative expense

12.0m11.0m8.0m6.8m8.3m

Operating expense total

15.2m12.8m31.0m37.4m38.3m

Depreciation and amortization

2.4m2.4m

EBIT

(10.1m)(8.5m)(7.6m)(1.8m)(889.5k)

EBIT margin, %

(61%)(55%)(29%)(3%)(2%)

Interest expense

489.0k503.0k489.01.3m29.0k

Interest income

9.0k4.0k8.5k25.5k245.7k

Investment income

(686.0k)

Pre tax profit

(11.0m)(10.5m)(7.6m)(22.0m)(617.0k)

Income tax expense

1.0k12.0k65.5k144.8k137.1k

Net Income

(11.0m)(10.6m)(7.7m)(22.1m)(882.7k)

Cogentix Medical Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.7m788.0k1.2m2.0m9.4m20.9m

Accounts Receivable

2.1m3.6m3.8m8.2m6.8m8.3m

Prepaid Expenses

197.0k276.0k455.0k834.1k1.1m

Inventories

4.0m5.2m4.2m4.6m7.2m7.2m

Current Assets

9.0m9.8m9.7m15.6m37.5m43.7m

PP&E

2.0m1.5m1.1m2.6m2.1m2.4m

Goodwill

18.7m18.7m19.2m

Total Assets

12.6m11.4m10.8m49.0m73.4m74.7m

Accounts Payable

587.0k1.3m1.2m2.2m2.7m3.0m

Short-term debt

91.0k75.0k22.0k

Current Liabilities

3.0m2.9m2.8m6.5m8.9m9.4m

Long-term debt

97.0k22.0k22.4m23.3m

Total Debt

188.0k97.0k22.4m23.3m

Total Liabilities

13.0m20.0m25.3m32.0m10.1m10.7m

Common Stock

454.0k463.0k476.0k260.6k609.1k

Preferred Stock

Additional Paid-in Capital

98.4m100.8m102.6m76.5m144.4m146.0m

Retained Earnings

(99.3m)(109.8m)(117.5m)(58.9m)(81.0m)(82.0m)

Total Equity

(449.0k)(8.6m)(14.5m)17.0m63.2m64.0m

Debt to Equity Ratio

-0.4 x0 x-1.5 x1.4 x

Debt to Assets Ratio

0 x0 x2.1 x0.5 x

Financial Leverage

-28.1 x-1.3 x-0.7 x2.9 x1.2 x1.2 x

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

5.2m2.9m3.0m455.0k1.1m1.3m1.4m1.5m6.0m2.9m2.2m2.9m4.2m5.7m10.4m15.4m

Accounts Receivable

1.2m1.7m1.6m2.8m3.4m2.9m4.1m6.5m6.5m6.9m6.5m6.8m6.7m7.3m7.2m

Prepaid Expenses

426.0k376.0k269.0k393.0k313.0k460.0k513.0k902.3k1.6m854.3k774.1k562.8k701.7k616.2k988.0k

Inventories

6.8m6.3m5.3m5.7m5.4m4.2m4.2m4.3m4.9m5.0m5.0m5.7m6.2m7.6m7.2m7.4m

Current Assets

13.6m11.2m10.1m9.3m10.2m9.2m9.0m10.4m18.2m16.0m14.9m15.8m19.1m36.7m39.9m41.6m

PP&E

2.4m2.3m2.1m1.3m1.2m986.0k922.0k2.0m2.6m2.5m2.3m2.2m2.1m2.2m2.5m

Goodwill

18.7m18.7m18.7m18.7m18.7m18.7m18.7m19.2m

Total Assets

16.2m15.4m14.0m10.7m11.5m10.4m10.0m11.4m52.4m50.2m47.7m47.8m50.5m70.7m71.5m74.0m

Accounts Payable

848.0k748.0k403.0k1.2m1.1m1.1m1.4m2.1m3.9m3.3m2.2m2.3m3.1m2.0m1.6m2.1m

Short-term debt

103.0k97.0k99.0k46.0k34.0k198.2k

Current Liabilities

6.5m5.0m3.6m2.7m2.8m3.1m3.1m3.9m8.9m7.9m5.5m8.0m10.1m7.2m7.2m9.0m

Long-term debt

154.0k143.0k115.0k20.0m21.8m24.5m26.5m22.8m23.1m23.6m23.9m24.2m289.4k

Total Debt

257.0k240.0k214.0k20.0m21.8m24.5m26.5m22.8m23.1m23.6m23.9m24.2m198.2k

Total Liabilities

11.6m11.1m11.7m22.8m24.7m27.7m30.4m32.9m32.7m31.6m34.3m36.7m8.3m8.2m10.4m

Common Stock

444.0k447.0k447.0k464.0k476.0k478.0k484.0k260.5k260.6k259.5k260.4k265.4k604.4k609.1k609.1k

Preferred Stock

Additional Paid-in Capital

95.0m97.6m98.0m101.1m101.5m102.8m103.0m103.2m75.7m76.1m76.6m76.7m76.9m144.9m145.2m145.7m

Retained Earnings

(90.9m)(93.8m)(96.2m)(113.6m)(115.1m)(119.5m)(121.1m)(122.6m)(55.5m)(57.8m)(59.9m)(62.5m)(62.4m)(82.3m)(81.9m)(82.1m)

Total Equity

4.6m4.2m2.3m(12.1m)(13.2m)(17.7m)(19.0m)19.4m17.5m16.1m13.5m13.8m62.4m63.3m63.6m

Debt to Equity Ratio

0.1 x0.1 x0.1 x-1.7 x-1.6 x-1.4 x-1.4 x1.2 x1.3 x1.5 x1.8 x1.8 x0 x

Debt to Assets Ratio

0 x0 x0 x1.9 x1.9 x2.4 x2.3 x0.4 x0.5 x0.5 x0.5 x0.5 x0 x

Financial Leverage

3.5 x3.6 x6.1 x-0.9 x-0.9 x-0.6 x-0.6 x2.7 x2.9 x3 x3.5 x3.7 x1.1 x1.1 x1.2 x

Cogentix Medical Cash Flow

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(11.0m)(10.6m)(7.7m)(7.0m)(22.1m)(882.7k)

Depreciation and Amortization

832.0k795.0k695.0k2.6m3.1m3.2m

Accounts Receivable

539.0k(1.5m)(215.0k)(1.7m)1.4m(661.8k)

Inventories

(1.8m)(1.4m)692.0k246.3k(2.7m)276.1k

Accounts Payable

(334.0k)713.0k(83.0k)(1.8m)484.2k(90.3k)

Cash From Operating Activities

(11.6m)(9.6m)(5.9m)(5.9m)3.3m2.3m

Purchases of PP&E

(209.0k)(95.0k)(53.0k)(1.4m)(355.1k)(856.9k)

Cash From Investing Activities

(199.0k)(90.0k)(50.0k)(1.4m)(19.3m)9.5m

Short-term Borrowings

(3.1m)

Long-term Borrowings

(87.0k)(91.0k)(58.0k)

Cash From Financing Activities

5.3m7.9m6.4m23.4m(276.6k)

Net Change in Cash

(6.5m)(1.9m)449.0k(7.3m)7.4m11.5m

Interest Paid

425.0k592.0k8.0k30.2k62.4k13.8k

Income Taxes Paid

4.0k17.0k11.0k39.8k43.0k284.4k

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(2.6m)(5.6m)(7.9m)(3.8m)(5.3m)(2.0m)(3.5m)(5.1m)(3.6m)(5.9m)(966.4k)(3.6m)(3.5m)(1.2m)(790.8k)(950.9k)

Depreciation and Amortization

189.0k402.0k618.0k362.0k532.0k318.0k466.0k853.2k1.7m806.6k1.6m2.4m769.8k1.5m2.3m

Accounts Receivable

(405.0k)97.0k(36.0k)802.0k198.0k887.0k(258.0k)816.1k53.3k1.3m1.7m1.4m68.5k(403.0k)271.0k

Inventories

777.0k429.0k(508.0k)(712.0k)(465.0k)(261.0k)(408.0k)(44.0k)(134.7k)(447.7k)(1.1m)(1.6m)(373.7k)7.3k57.3k

Accounts Payable

(73.0k)(173.0k)(518.0k)(112.0k)(215.0k)188.0k847.0k(90.0k)(647.3k)13.5k104.1k394.6k(702.0k)(1.1m)(898.8k)

Cash From Operating Activities

(4.1m)(7.5m)(9.4m)(3.2m)(4.5m)(1.8m)(3.7m)(2.9m)(5.1m)304.4k1.1m2.9m(2.3m)(890.2k)1.6m

Purchases of PP&E

(76.0k)(106.0k)(127.0k)(46.0k)(53.0k)(17.0k)(47.0k)(395.4k)(1.2m)(137.8k)(167.0k)(232.3k)(133.0k)(398.4k)(680.4k)

Cash From Investing Activities

(76.0k)(103.0k)(124.0k)(43.0k)(50.0k)(17.0k)(47.0k)(395.4k)(1.2m)(137.8k)(167.0k)(232.3k)(1.4m)2.0m4.6m

Short-term Borrowings

2.6m(2.4m)(3.0m)(3.0m)

Long-term Borrowings

(18.0k)(35.0k)(61.0k)(34.0k)(46.0k)(22.0k)(22.0k)

Cash From Financing Activities

185.0k1.3m3.3m2.9m4.9m2.0m4.0m(375.8k)4.0k4.0k(178.4k)

Net Change in Cash

(4.0m)(6.3m)(6.2m)(333.0k)334.0k158.0k311.0k(3.3m)(6.3m)179.9k890.5k2.3m(3.7m)1.1m6.0m

Interest Paid

98.0k196.0k301.0k4.0k11.0k1.0k1.0k1.4k8.0k19.4k34.1k47.8k13.5k13.6k13.7k

Income Taxes Paid

3.0k3.0k4.0k3.0k11.0k17.6k16.7k14.6k19.4k35.4k110.6k135.9k152.9k

Cogentix Medical Ratios

USDY, 2017

Revenue/Employee

316.4k

Financial Leverage

1.2 x

Cogentix Medical Employee Rating

4.05 votes
Culture & Values
3.6
Work/Life Balance
4.6
Senior Management
4.2
Salary & Benefits
4.0
Career Opportunities
3.5
Source